Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology
Free Medical Books

  Leukemia

  Free Subscription


26.12.2011

1 Am J Clin Pathol
1 Am J Hematol
9 Blood
1 Bone Marrow Transplant
2 Cancer
1 Exp Cell Res
1 Int J Hematol
1 J Biol Chem
7 J Clin Oncol
1 J Immunol
1 J Pediatr Hematol Oncol
3 Leuk Lymphoma
1 Leuk Res
2 Leukemia
1 N Engl J Med


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Clin Pathol

  1. MEYERSON HJ , Blidaru G, Edinger A, Osei E, et al
    NRP-1/CD304 Expression in Acute Leukemia: A Potential Marker for Minimal Residual Disease Detection in Precursor B-Cell Acute Lymphoblastic Leukemia.
    Am J Clin Pathol. 2012;137:39-50.
    PubMed     Text format     Related articles    Abstract available



    Am J Hematol

  2. ESTEY EH
    Acute myeloid leukemia: 2012 update on diagnosis, risk stratification, and management.
    Am J Hematol. 2012;87:89-99.
    PubMed     Text format     Related articles    Abstract available



    Blood

  3. RUCKER FG , Schlenk RF, Bullinger L, Kayser S, et al
    TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available


  4. O'CALLAGHAN K , Lee L, Nguyen N, Hsieh MY, et al
    Targeting CXCR4 with cell-penetrating pepducins in lymphoma and lymphocytic leukemia.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available


  5. HAMILTON A , Helgason GV, Schemionek M, Zhang B, et al
    Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available


  6. PONADER S , Chen SS, Buggy JJ, Balakrishnan K, et al
    Bruton's tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available


  7. WAGNER JE , Blazar BR
    Resurrecting the recalcitrant T-cell.
    Blood. 2011;118:4302-3.
    PubMed     Text format     Related articles   


  8. JACOBSOHN DA , Arora M, Klein JP, Hassebroek A, et al
    Risk factors associated with increased non-relapse mortality and with poor overall survival in children with chronic graft-versus-host disease.
    Blood. 2011.
    PubMed     Text format     Related articles    Abstract available


  9. KOJIMA K , McQueen T, Chen Y, Jacamo R, et al
    p53 activation of mesenchymal stromal cells partially abrogates microenvironment-mediated resistance to FLT3 inhibition in AML through HIF-1alpha-mediated down-regulation of CXCL12.
    Blood. 2011;118:4431-9.
    PubMed     Text format     Related articles    Abstract available


  10. CALPE E , Codony C, Baptista MJ, Abrisqueta P, et al
    ZAP-70 enhances migration of malignant B lymphocytes toward CCL21 by inducing CCR7 expression via IgM-ERK1/2 activation.
    Blood. 2011;118:4401-10.
    PubMed     Text format     Related articles    Abstract available


  11. MERINDOL N , Champagne MA, Duval M, Soudeyns H, et al
    CD8(+) T-cell reconstitution in recipients of umbilical cord blood transplantation and characteristics associated with leukemic relapse.
    Blood. 2011;118:4480-8.
    PubMed     Text format     Related articles    Abstract available



    Bone Marrow Transplant

  12. HUANG J , Zou DH, Li ZJ, Fu MW, et al
    An auto-SCT-based total therapy resulted in encouraging outcomes in adolescents and young adults with acute lymphoblastic leukemia: report from a single center of China.
    Bone Marrow Transplant. 2011 Dec 19. doi: 10.1038/bmt.2011.
    PubMed     Text format     Related articles    Abstract available



    Cancer

  13. ABDULWAHAB A , Sykes J, Kamel-Reid S, Chang H, et al
    Therapy-related acute lymphoblastic leukemia is more frequent than previously recognized and has a poor prognosis.
    Cancer. 2011 Dec 16. doi: 10.1002/cncr.26735.
    PubMed     Text format     Related articles    Abstract available


  14. MONK JP , Halabi S, Picus J, Hussain A, et al
    Efficacy of peripheral androgen blockade in prostate cancer patients with biochemical failure after definitive local therapy: Results of Cancer and Leukemia Group B (CALGB) 9782.
    Cancer. 2011 Dec 16. doi: 10.1002/cncr.26732.
    PubMed     Text format     Related articles    Abstract available



    Exp Cell Res

  15. FUCHS R , Schraml E, Leitinger G, Stelzer I, et al
    alpha1-Adrenergic drugs modulate differentiation and cell death of human erythroleukemia cells through non adrenergic mechanism.
    Exp Cell Res. 2011;317:2239-51.
    PubMed     Text format     Related articles    Abstract available



    Int J Hematol

  16. YOKOHAMA A , Saitoh A, Nakahashi H, Mitsui T, et al
    TCL1A gene involvement in T-cell prolymphocytic leukemia in Japanese patients.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available



    J Biol Chem

  17. MANAVATHI B , Lo D, Bugide S, Dey O, et al
    Functional regulation of pre-B-cell leukemia homeobox interacting protein 1 (PBXIP1/HPIP) in erythroid differentiation.
    J Biol Chem. 2011.
    PubMed     Text format     Related articles    Abstract available



    J Clin Oncol

  18. FERRARA F
    Prediction of Early Death in Acute Myeloid Leukemia.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   


  19. GOPALUNI S , Sanyal S, Bair A, Vajpayee N, et al
    Hairy Cell Leukemia Variant in a Patient With Chronic Myeloid Leukemia Receiving Nilotinib: Sequential or Coincidental?
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   


  20. WALENSKY LD
    From Mitochondrial Biology to Magic Bullet: Navitoclax Disarms BCL-2 in Chronic Lymphocytic Leukemia.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   


  21. HILLMEN P
    Targeted Therapy for Chronic Lymphocytic Leukemia: A Glimpse Into the Future.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   


  22. ROBERTS AW , Seymour JF, Brown JR, Wierda WG, et al
    Substantial Susceptibility of Chronic Lymphocytic Leukemia to BCL2 Inhibition: Results of a Phase I Study of Navitoclax in Patients With Relapsed or Refractory Disease.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available


  23. CORTES JE
    Not Only Response but Early Response to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   


  24. SWERDLOW AJ , Higgins CD, Smith P, Cunningham D, et al
    Second Cancer Risk After Chemotherapy for Hodgkin's Lymphoma: A Collaborative British Cohort Study.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



    J Immunol

  25. CUDA CM , Li S, Liang S, Yin Y, et al
    Pre-B Cell Leukemia Homeobox 1 Is Associated with Lupus Susceptibility in Mice and Humans.
    J Immunol. 2011.
    PubMed     Text format     Related articles    Abstract available



    J Pediatr Hematol Oncol

  26. AVRAMIS VI
    Asparaginases: a successful class of drugs against leukemias and lymphomas.
    J Pediatr Hematol Oncol. 2011;33:573-9.
    PubMed     Text format     Related articles   



    Leuk Lymphoma

  27. TANTIWORAWIT A , Power MM, Barnett MJ, Hogge DE, et al
    Long-term Follow-up of Patients with Chronic Myeloid Leukemia in Chronic Phase Developing Sudden Blast Phase on Imatinib Therapy.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available


  28. WANG H , Geng QR, Wang L, Lu Y, et al
    Curcumin potentiates antitumor activity of L-asparaginase via inhibition of AKT signaling pathway in acute lymphoblastic leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available


  29. CAMGOZ A , Gencer EB, Ural AU, Avcu F, et al
    Roles of ceramide synthase and ceramide clearence genes in nilotinib-induced cell death in chronic myeloid leukemia cells.
    Leuk Lymphoma. 2011;52:1574-84.
    PubMed     Text format     Related articles    Abstract available



    Leuk Res

  30. SAVIC A , Kvrgic V, Rajic N, Urosevic I, et al
    The hematopoietic cell transplantation comorbidity index is a predictor of early death and survival in adult acute myeloid leukemia patients.
    Leuk Res. 2011.
    PubMed     Text format     Related articles    Abstract available



    Leukemia

  31. SHEDDEN K , Li Y, Ouillette P, Malek SN, et al
    Characteristics of chronic lymphocytic leukemia with somatically acquired mutations in NOTCH1 exon 34.
    Leukemia. 2011 Dec 20. doi: 10.1038/leu.2011.
    PubMed     Text format     Related articles   


  32. CONGLETON J , Macdonald R, Yen A
    Src inhibitors, PP2 and dasatinib, increase retinoic acid-induced association of Lyn and c-Raf (S259) and enhance MAPK dependent differentiation of myeloid leukemia cells.
    Leukemia. 2011 Dec 19. doi: 10.1038/leu.2011.
    PubMed     Text format     Related articles    Abstract available



    N Engl J Med

  33. LANDGREN O , Thomas A, Mailankody S
    Myeloma and second primary cancers.
    N Engl J Med. 2011;365:2241-2.
    PubMed     Text format     Related articles   



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: